Clinical

Dataset Information

0

Simultaneous Integrated Boost Preoperative Radiotherapy for Rectum Cancer


ABSTRACT: The investigators propose a randomized non-inferiority trial that compares preoperative Fluoro Uracil (FU)-based chemoradiotherapy to radiotherapy with a simultaneous integrated boost. In patients with T3-4 rectal cancer, the latter approach is considered preferential with regard to toxicity and cost. The metabolic response of the tumor, as assessed by 18F-2-Fluoro-2-Deoxyglucose-Positron Emission tomography (18F-FDG PET) or PET-CT, will be used as a surrogate marker of cause specific outcome

DISEASE(S): Rectal Neoplasms,Colorectal Cancer,Colorectal Neoplasms,Rectal Cancer

PROVIDER: 2096816 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| phs001784 | dbGaP
2021-08-30 | GSE178901 | GEO
| 2018360 | ecrin-mdr-crc
2022-11-29 | GSE218758 | GEO
2023-12-19 | GSE247303 | GEO
2022-04-05 | GSE164961 | GEO
2023-04-14 | GSE227581 | GEO
2018-01-01 | GSE69581 | GEO
2018-07-06 | GSE113764 | GEO
2023-01-31 | GSE222874 | GEO